Literature DB >> 3603404

Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements.

A P Streissguth, R P Treder, H M Barr, T H Shepard, W A Bleyer, P D Sampson, D C Martin.   

Abstract

In a longitudinal prospective study of 1,529 women pregnant in 1974-1975, aspirin and acetaminophen were the two medications most frequently taken during the first half of pregnancy (46 and 41%, respectively). In a selected cohort of 421 offspring of these women, examined at 4 years of age, maternal aspirin use during the first half of pregnancy was significantly related to IQ and attention decrements in the exposed children. Multiple regression analyses were used to statistically adjust for a variety of potentially confounding factors including demographic characteristics, child characteristics, other exposures, and lifestyle/environmental variables. Continuous dose-response and step-function parameterizations of aspirin exposure were both statistically significant and not clearly distinguishable from each other. The estimated aspirin effect is significantly greater for girls than boys. Aspirin effects on offspring function were found in the absence of effects on physical size both at birth and at 4 years. Maternal acetaminophen use was not significantly related to child IQ or attention. As this exploratory research originated from observations of a data set gathered for other purposes, it would be desirable to have these findings replicated in other studies. Further follow-up of the children at a later age is planned.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3603404     DOI: 10.1002/tera.1420350207

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  13 in total

1.  Acetaminophen in pregnancy and future risk of ADHD in offspring.

Authors:  Jill A Blaser; G Michael Allan
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

2.  Maternal acetaminophen use during pregnancy and childhood behavioural problems: Discrepancies between mother- and teacher-reported outcomes.

Authors:  Samantha E Parker; Brent R Collett; Martha M Werler
Journal:  Paediatr Perinat Epidemiol       Date:  2019-11-06       Impact factor: 3.980

3.  Invited Commentary: The Disillusionment of Developmental Origins of Health and Disease (DOHaD) Epidemiology.

Authors:  Stephen E Gilman; Mady Hornig
Journal:  Am J Epidemiol       Date:  2020-01-31       Impact factor: 4.897

Review 4.  Ongoing Pharmacological Management of Chronic Pain in Pregnancy.

Authors:  Bengt Källén; Margareta Reis
Journal:  Drugs       Date:  2016-06       Impact factor: 9.546

5.  Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.

Authors:  De-Kun Li; Liyan Liu; Roxana Odouli
Journal:  BMJ       Date:  2003-08-16

6.  A survey of the administration of drugs to young infants. The Alspac Survey Team. Avon Longitudinal Study of Pregnancy and Childhood.

Authors:  N Hawkins; J Golding
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

7.  Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study.

Authors:  Ragnhild Eek Brandlistuen; Eivind Ystrom; Irena Nulman; Gideon Koren; Hedvig Nordeng
Journal:  Int J Epidemiol       Date:  2013-10-24       Impact factor: 7.196

Review 8.  Managing Migraine During Pregnancy and Lactation.

Authors:  Rebecca Erwin Wells; Dana P Turner; Michelle Lee; Laura Bishop; Lauren Strauss
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 9.  Pain Management in Pregnancy: Multimodal Approaches.

Authors:  Shalini Shah; Esther T Banh; Katharine Koury; Gaurav Bhatia; Roneeta Nandi; Padma Gulur
Journal:  Pain Res Treat       Date:  2015-09-13

10.  Consumption habits of pregnant women and implications for developmental biology: a survey of predominantly Hispanic women in California.

Authors:  Sarah E Santiago; Grace H Park; Kelly J Huffman
Journal:  Nutr J       Date:  2013-07-01       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.